Copyright
©2014 Baishideng Publishing Group Inc.
World J Pharmacol. Dec 9, 2014; 3(4): 56-71
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.56
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.56
Table 1 Pregnancy associated asthma morbidity by severity classification
Mild asthma n (%) | Moderate asthma n (%) | Severe asthma n (%) | ||||
Schatz et al[51] | Murphy et al[55] | Schatz et al[51] | Murphy et al[55] | Schatz et al[51] | Murphy et al[55] | |
(n = 873) | (n = 63) | (n = 814) | (n = 34) | (n = 52) | (n = 49) | |
Asthma Exacerbation | 110 (12.6) | 5 (8) | 209 (25.7)b | 16 (47) | 27 (51.9)d | 32 (65) |
Unscheduled physician or ED presentation | 99 (11.3) | 4 (6.3) | 157 (19.3)b | 14 (41) | 19 (36.5)b | 20 (41) |
Oral corticosteroid use | 19 (2.2) | 0 (0) | 71 (8.7)b | 4 (11.8) | 20 (38.5)b | 19 (38.8) |
Hospitalization | 20 (2.3) | 2 (3.2) | 55 (6.8)b | 1 (2.9) | 14 (26.9)b | 9 (18.4) |
- Citation: Blackburn HK, Allington DR, Procacci KA, Rivey MP. Asthma in pregnancy. World J Pharmacol 2014; 3(4): 56-71
- URL: https://www.wjgnet.com/2220-3192/full/v3/i4/56.htm
- DOI: https://dx.doi.org/10.5497/wjp.v3.i4.56